Juda, A. et al. 2022. The use of the GLP-1 analog - dulaglutide in the treatment of morbid obesity - case report. Journal of Education, Health and Sport. 13, 1 (Nov. 2022), 146–152. DOI:https://doi.org/10.12775/JEHS.2023.13.01.023.